Search

You searched for "ophthalmologist"

3144 results found

Acetylcholine receptor antibodies in the diagnosis of ocular myasthenia gravis at the Manchester Royal Eye Hospital

3 August 2023 | | EYE - Neuro-ophthalmology
Myasthenia gravis (MG) is the commonest autoimmune condition to affect the neuromuscular junction. In the UK, its prevalence is 15 per 10,000 [1,2] and recent studies have shown that rates are steadily increasing [3,4]. Aims of this audit The aim...

Vitreous loss fire drills – ophthalmic simulation improves trainee surgical competence and confidence with posterior capsule rupture scenarios

4 December 2023 | | EYE - Cataract, EYE - Refractive
Ophthalmic trainees have reported limited exposure and low confidence regarding the management of cataract complications such as posterior capsule rupture (PCR) / vitreous loss (VL). This report evaluates the impact of a simulation-based educational training event on these concerns. Introduction...

Sickle cell eye disease: an overview of vitreoretinal complications and their surgical management

1 December 2016 | | EYE - Vitreo-Retinal
Sickle cell disease is the most common genetic disorder worldwide and is associated with lifelong anaemia, intermittent pain and multi-organ morbidity. Ocular involvement can be associated with significant visual impairment due to the complications of proliferative sickle retinopathy (PSR). Occasionally...

Congenital cranial dysinnervation disorders (CCDDs)

3 October 2022 | | EYE - General
The term congenital cranial dysinnervation disorder (CCDD) was introduced by Gutowski et al. in 2003 to describe strabismus conditions that result from developmental error in innervation of some of the extraocular muscles. Examples of these conditions include Duane’s syndrome and...

Good news: new study links moderate wine consumption to lower risk of cataract surgery

31 March 2021
An observational study published today in Ophthalmology (the journal of the American Academy of Ophthalmology) indicates that low to moderate alcohol consumption is associated with a lower risk of requiring surgery for cataracts, although the nature of the study means it does not definitively prove a direct causal effect.

A European ophthalmology perspective

1 October 2014 | | EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Europe: from the Greek eurus: broad, wide, and ops: eye, face, sight. Thus Europe = the far-sighted (lady). For my first contribution to this column – as the successor of Jonathan Park, whose witty observations and entertaining style many of...

HOYA Vision Care’s Defocus Incorporated Multiple Segments Spectacle Lenses demonstrated significant trend of myopia control in children

24 September 2024 | optometry, contact lenses, myopia, Paediatric, research, new study, EPOS 2024
Interim analysis from the Observational French Study in children presented at EPOS 2024 meeting in Paris. Data from an interim analysis of the Observational French Study, OPHTAMYOP, has demonstrated a significant trend of myopia control in children with spherical equivalent...

Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up

29 March 2023 | glaucoma
Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.

Eye scans detect signs of Parkinson’s disease up to seven years before diagnosis

22 August 2023 | moorfields, Parkinson's disease, Siegfried Wagner, Pearse Keane, UCL Institute of Ophthalmology, early detection
A team led by Siegfried Wagner and Pearse Keane of Moorfields Eye Hospital and UCL Institute of Ophthalmology (and spanning UCL institutions) has identified markers that indicate the presence of Parkinson’s disease in patients on average seven years before clinical presentation.

OSA Insights to Market win praise from members

31 October 2023 | OSA, Meetings, Events, Market insight, Opticians, E-Health
OSA members praised the breadth of optical market insights provided by the Autumn meeting this week as a broad spectrum of suppliers gathered in London, reinforcing the strength of the trade body.

Treatment for cause of sudden sight loss now available through the NHS in England

24 September 2025 | LHON, NICE, vision Loss, mitochondrial disease, NHS England
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...

NICE approves treatment for cause of sudden sight loss

15 October 2025 | genetics, neuro-ophthalmology, drugs, new treatments, mitochondrial
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...